Jazz Pharmaceuticals plc

Company Overview

Jazz Pharmaceuticals Inc. is a biopharmaceutical company dedicated to developing innovative medicines for serious diseases, particularly those with limited treatment options. Its portfolio includes sleep disorders, epilepsy, and cancer treatments. With a patient-centric and science-driven approach and are actively advancing a robust pipeline of therapeutics in oncology and neuroscience. The organization aims to enhance patients’ and their families’ lives through innovation by developing medicines that significantly aid those with serious illnesses by transforming scientific discoveries into effective treatments.

The company operates in two business segments – Neuroscience and Oncology. There are 2,800 employees as of December 31, 2024, and it have a prominent presence in the U.S., Europe, and around seventy-five countries.

Financial Highlights (FY 2024)

Company's Business Segments

• Oncology and Neuroscience : The company develops and commercializes medicines, particularly for narcolepsy, cancer, pain, and psychiatry, focusing on unmet medical needs.